FEATURED BLOGS
Feb 14, 2019
It's hard enough to try dating again after a cancer diagnosis and treatment, but some of my patients also face strong opposition from their adult children.
Feb 14, 2019
Dr. Suneel D. Kamath was surprised to learn how important laughter and levity can be in the physician-patient relationship.
Feb 07, 2019
Dr. Gottlieb discusses the FDA's efforts to increase overall efficiency by updating or modernizing aspects of our clinical trials conduct and expediting the end-to-end drug development process, as...
Feb 04, 2019
A recent study should serve as a wake-up call to all Americans that obesity is linked to an increased risk of common cancers.
Feb 01, 2019
Dr. Evangelia Razis will speak out about cancer and fight against the guilt and shame that attend a cancer diagnosis.
Feb 01, 2019
On February 3, Dr. Stephanie Graff hopes women in every aspect of medicine will feel inspired to choose themselves, and make their own wellness a priority.
Jan 29, 2019
Immunotherapy—particularly immune checkpoint inhibition—is still experimental. It ends up being quite a difficult discussion for some who had hoped that they could stave off chemotherapy.

Advertisement

Latest Comments & Discussions


Jason R. Westin, MD
Feb 18, 2019
Course Faculty Response Early relapse of diffuse large B-cell lymphoma implies a poor prognosis with an increased chance of chemotherapy...

ASCO University
Feb 18, 2019
Course Faculty Response (Dr. Alexandra Kovach) Biopsy of an accessible lymph node to confirm relapse is highly suggested. The unlikely...

ASCO University
Feb 11, 2019
Discussion Questions 1. What additional pathology testing, on tumor or blood, would be potentially useful? 2. What treatment options...

ASCO University
Feb 11, 2019
Patient Case Update FISH studies detect translocations involving MYC and BCL2 and multiple copies, but no rearrangement, of BCL6. The...

ASCO University
Feb 11, 2019
  Course Faculty Response (Alexandra Kovach, MD) Diffuse large B-cell lymphoma, not otherwise specified (DLBCL-NOS) encompasses...

Pages

Most Read

Clinical trials, a vital aspect of cancer research, can result in new, effective treatments that can help people with cancer live longer, healthier lives. So why is the participation so low?
When a patient asks, "Why me?", Dr. Stephanie Graff considers that they may not be asking for a list of their cancer risk factors.
Immunotherapy—particularly immune checkpoint inhibition—is still experimental. It ends up being quite a difficult discussion for some who had hoped that they could stave off chemotherapy.
On February 3, Dr. Stephanie Graff hopes women in every aspect of medicine will feel inspired to choose themselves, and make their own wellness a priority.
Dr. Evangelia Razis will speak out about cancer and fight against the guilt and shame that attend a cancer diagnosis.

Tweets from ASCO

Tweets from Oncology Community